Sponsors

Accreditation for cell-mediated immune response assay services

ProImmune, a provider of services for immune monitoring, antigen discovery and immunogenicity risk assessment, has been accepted into the UK Good Laboratory Practice (GLP) monitoring programme by Medicines and Healthcare products Regulatory Agency (MHR), confirming ProImmune’s compliance with GLP.

This accreditation will enable companies worldwide to incorporate ProImmune’s GLP- and Good Clinical Practice (GCP)-compliant services, such as cell-mediated immunity assays, into their preclinical and clinical development programmes with the confidence that the data will meet the different international regulatory submission requirements. Cell-mediated immune response assays are notoriously difficult, time-consuming and costly to implement in-house. Therefore, access to ProImmune’s GLP- and GCP-compliant assays provides an outsourcing solution for developers of new therapies.
www.proimmune.com

Latest Issues

BDIAP Molecular Pathology Study Day

10 Union Street, London, SE1 1SZ
2 March, 2026

Cell & Gene Therapy 2026

Hinxton Hall Conference Centre, Wellcome Genome Campus, Hinxton, CB10 1RQ
9-10 March, 2026

USCAP 115th Annual Meeting

Henry B. González Convention Center, San Antonio, Texas, USA
21-26 March, 2026